Stocktoria

JUPITER NEUROSCIENCES, INC. JUNS

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2024-12-03

JUPITER NEUROSCIENCES, INC. statistics & valuation

Net margin-39662.8%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-39662.80% 202320242025
Gross margin (%)
80.60% 202320242025
Operating margin (%)
-40873.20% 202320242025
Return on equity (%)
-58.50% 202320242025
Shares outstanding
26.5M 33.1M 34.6M 202320242025
Net debt ($)
202320242025
Share buybacks ($)
202320242025
Return on assets (%)
-3219.30% -39.30% -155.40% 202320242025
Free cash flow margin (%)
202320242025
Debt / equity (×)
202320242025
EPS ($)
-$0.18 -$0.08 -$0.25 202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023
Gross margin80.6%
Operating margin-40873.2%
Net margin-39662.8%
Return on assets-155.4%-39.3%-3219.3%
Return on equity471.9%-58.5%82.5%
Current ratio0.652.310.00

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.